Approval · Notice of Compliance 23063 · 2020
EVICTO: Notice of Compliance 23063
Issued January 2, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23063
- Date
- January 2, 2020
- Company
- Virbac Ah, Inc.Fort Worth, Texas, United States
- Product type
- Veterinary
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- REVOLUTION (Zoetis Canada Inc)
Products in this notice
Medicinal ingredients
- SELAMECTIN 15 MG per 0.25ML
- SELAMECTIN 30 MG per 0.25ML
- SELAMECTIN 45 MG per 0.75ML
- SELAMECTIN 60 MG per 0.5ML
- SELAMECTIN 60 MG per ML
- SELAMECTIN 120 MG per ML
- SELAMECTIN 240 MG per 2ML
- SELAMECTIN 360 MG per 3ML